Aradhana Sarin
President bei ACHILLION PHARMACEUTICALS, INC.
Vermögen: 11 Mio $ am 31.03.2024
Profil
Dr. Aradhana Sarin ist President & Director bei Achillion Pharmaceuticals, Inc. und Chief Financial Officer & Executive Vice President bei Alexion Pharmaceuticals, Inc. Er ist Mitglied des Board of Directors bei Achillion Pharmaceuticals, Inc. Dr. Sarin war zuvor als unabhängiger Direktor bei OraSure Technologies, Inc. beschäftigt, als MD-Healthcare Corporate & Investment Banking bei Citizens, Inc. (Austin, Texas), und als Managing Director-Healthcare Investment Banking bei der UBS AG. Er erhielt seinen MBA von der Stanford Graduate School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ASTRAZENECA PLC
0,01% | 31.12.2023 | 82 514 ( 0,01% ) | 11 Mio $ | 31.03.2024 |
Aktuelle Nachrichten zu Aradhana Sarin
Aktive Positionen von Aradhana Sarin
| Unternehmen | Position | Beginn |
|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | President | 28.01.2020 |
| ASTRAZENECA PLC | Director of Finance/CFO | 01.08.2021 |
| ANHEUSER-BUSCH INBEV SA/NV | Director/Board Member | 26.04.2023 |
Ehemalige bekannte Positionen von Aradhana Sarin
| Unternehmen | Position | Ende |
|---|---|---|
| CITIZENS, INC. | Corporate Officer/Principal | 01.10.2017 |
| UBS | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
| ORASURE TECHNOLOGIES, INC. | Director/Board Member | - |
Ausbildung von Aradhana Sarin
| University of Delhi | Doctorate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| CITIZENS, INC. | Finance |
| ASTRAZENECA PLC | Health Technology |
| ORASURE TECHNOLOGIES, INC. | Health Technology |
| ANHEUSER-BUSCH INBEV SA/NV | Consumer Non-Durables |
| Private Unternehmen | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
UBS AG
 UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
